carbostyril has been researched along with Anxiety Disorders in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Citrome, LL; Manning, JS; McIntosh, D; McIntyre, RS | 1 |
| Brawman-Mintzer, O; Gros, DF; Hershenberg, R | 1 |
| Boursi, B; Haynes, K; Lurie, I; Mamtani, R; Yang, YX | 1 |
| Popkin, MK | 1 |
| McIntyre, RS; Weiller, E; Weiss, C; Zhang, P | 1 |
| Delong, HR; Hoge, EA; Kaufman, RE; Pollack, MH; Simon, NM; Worthington, JJ | 1 |
| Berman, RM; Carlson, BX; Fava, M; Marcus, RN; Nelson, CJ; Pikalov, A; Qi, Y; Thase, ME; Tran, QV; Trivedi, MH; Yang, H | 1 |
| Baker, RA; Berman, RM; Carlson, BX; Eudicone, JM; Mankoski, R; Nelson, JC; Pikalov, A; Tran, QV | 1 |
| Jackson, CW; Lorenz, RA; Saitz, M | 1 |
| McIntyre, RS | 1 |
| Katzman, MA | 1 |
| Bojarski, AJ; Glowka, ML; Lewgowd, W; Mordalski, S; Olczak, A; Stanczak, A; Szczesio, M | 1 |
| Sajatovic, M | 1 |
| Basile, AS; Lippa, AS; Skolnick, P | 1 |
| Kinrys, G; Pollack, MH; Worthington, JJ; Wygant, LE | 1 |
| Adson, DE; Fahnhorst, TA; Kushner, MG | 1 |
| Dobkin, RD; Marin, H; Menza, MA | 1 |
| Masand, PS; Pae, CU; Patkar, AA; Serretti, A | 1 |
6 review(s) available for carbostyril and Anxiety Disorders
| Article | Year |
|---|---|
Role of atypical antipsychotics in the treatment of generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Generalization, Psychological; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Treatment Outcome | 2014 |
Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Drug Resistance; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2010 |
Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Anxiety Disorders; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Mental Disorders; Piperazines; Quinolones | 2011 |
Treatment for mood and anxiety disorders: quetiapine and aripiprazole.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Dibenzothiazepines; Humans; Mood Disorders; Piperazines; Quetiapine Fumarate; Quinolones | 2003 |
Anxioselective anxiolytics: can less be more?
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepinones; Carbolines; Clinical Trials as Topic; Fluorobenzenes; GABA-A Receptor Agonists; Humans; Indoles; Pyrroles; Quinolones; Triazoles | 2004 |
Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence.
Topics: Animals; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Depressive Disorder; Humans; Piperazines; Quinolones | 2008 |
6 trial(s) available for carbostyril and Anxiety Disorders
| Article | Year |
|---|---|
Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Depression; Depressive Disorder, Major; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychomotor Agitation; Quinolones; Serotonin Agents; Thiophenes; Treatment Outcome | 2016 |
Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Body Weight; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Quinolones; Treatment Outcome | 2008 |
Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2010 |
Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2005 |
Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors.
Topics: Adult; Aged; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2005 |
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Bupropion; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |
6 other study(ies) available for carbostyril and Anxiety Disorders
| Article | Year |
|---|---|
Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Arousal; Comorbidity; Delayed-Action Preparations; Depressive Disorder, Major; Drug Approval; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Practice Patterns, Physicians'; Quality of Life; Quetiapine Fumarate; Quinolones; Sleep Initiation and Maintenance Disorders; Thiophenes | 2019 |
Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Anxiety Disorders; Case-Control Studies; Databases, Factual; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Penicillins; Psychotic Disorders; Quinolones; Risk; Sulfonamides; United Kingdom; Young Adult | 2015 |
Gastrointestinal disorders and "medical depression".
Topics: Anti-Bacterial Agents; Antifungal Agents; Anxiety Disorders; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Penicillins; Psychotic Disorders; Quinolones; Sulfonamides | 2015 |
Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Panic Disorder; Personality Inventory; Piperazines; Prospective Studies; Quinolones; Treatment Outcome | 2008 |
Aripiprazole: striving towards euthymia with a novel mechanism of action.
Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Humans; Mood Disorders; Piperazines; Quinolones | 2011 |
Synthesis and structural investigation of some pyrimido[5,4-c]quinolin-4(3H)-one derivatives with a long-chain arylpiperazine moiety as potent 5-HT(1A/2A) and 5-HT(7) receptor ligands.
Topics: Anxiety Disorders; Binding Sites; Crystallography, X-Ray; Humans; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Piperazines; Protein Binding; Pyrimidines; Quinolones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin; Structure-Activity Relationship; Substrate Specificity | 2011 |